secwatch.observer — SEC 8-K summary
======================================

Issuer:     HUMANA INC (HUM)
CIK:        0000049071
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0000049071-25-000021
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humana Q1 GAAP EPS $10.30, Adjusted EPS $11.58; affirms FY adjusted EPS ~$16.25
-------------------------------------------------------------------------------

- Q1 GAAP EPS $10.30 vs $6.11 YoY; Adjusted EPS $11.58 vs $7.23 YoY; revenue $32.1B up 8.4%.
- Insurance segment benefit ratio 87.4% in line with ~87.5% expectation; affirms FY 2025 benefit ratio guidance 90.1%-90.5%.
- Revises FY 2025 GAAP EPS guidance to ~$14.68 from ~$15.88; affirms Adjusted EPS guidance ~$16.25.
- Expects individual Medicare Advantage membership decline of ~550k in 2025 due to planned plan exits.
- CenterWell selected as fulfillment pharmacy for NovoCare weight-loss drug; Illinois intends to award Dual Eligible SNP contract.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/49071/000004907125000021/0000049071-25-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/49071/000004907125000021/hum-20250430.htm
  HTML page:      https://secwatch.observer/filing/0000049071-25-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer